These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6770953

  • 21. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb N.
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract] [Full Text] [Related]

  • 22. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB, Ruedy J, Atkins CJ, Offer RC.
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [Abstract] [Full Text] [Related]

  • 23. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S, Inoue T.
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [Abstract] [Full Text] [Related]

  • 24. Does the order of second-line treatment in rheumatoid arthritis matter?
    Steven MM, Hunter JA, Murdoch RM, Capell HA.
    Br Med J (Clin Res Ed); 1982 Jan 09; 284(6309):79-81. PubMed ID: 6797663
    [Abstract] [Full Text] [Related]

  • 25. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis.
    Kvien TK, Høyeraal HM, Sandstad B.
    Scand J Rheumatol; 1985 Jan 09; 14(4):346-54. PubMed ID: 3936167
    [Abstract] [Full Text] [Related]

  • 26. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Smith PJ, Swinburn WR, Swinson DR, Stewart IM.
    Br Med J (Clin Res Ed); 1985 Jan 09; 285(6342):595-6. PubMed ID: 6218857
    [Abstract] [Full Text] [Related]

  • 27. Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine.
    Rantapää Dahlqvist S, Mjörndal T.
    Scand J Rheumatol; 1987 Jan 09; 16(4):235-9. PubMed ID: 3114874
    [Abstract] [Full Text] [Related]

  • 28. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP.
    Can Med Assoc J; 1980 Feb 23; 122(4):405-15. PubMed ID: 6768438
    [Abstract] [Full Text] [Related]

  • 29. D-penicillamine: chemistry and clinical use in rheumatic disease.
    Howard-Lock HE, Lock CJ, Mewa A, Kean WF.
    Semin Arthritis Rheum; 1986 May 23; 15(4):261-81. PubMed ID: 2940684
    [Abstract] [Full Text] [Related]

  • 30. Drug-induced IgA deficiency in rheumatoid arthritis.
    Stanworth DR, Williamson JP, Shadforth M, Felix-Davies D, Thompson R.
    Lancet; 1977 May 07; 1(8019):1001-2. PubMed ID: 67433
    [No Abstract] [Full Text] [Related]

  • 31. Proteinuria in rheumatoid arthritis--drug-induced or amyloid?
    Bourke BE, Woodrow DF, Scott JT.
    Ann Rheum Dis; 1981 Jun 07; 40(3):240-4. PubMed ID: 6787994
    [Abstract] [Full Text] [Related]

  • 32. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF, Dwosh IL, Anastassiades TP, Ford PM, Kelly HG.
    Arthritis Rheum; 1980 Feb 07; 23(2):158-64. PubMed ID: 7362666
    [Abstract] [Full Text] [Related]

  • 33. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R, Tvede N, Bendixen G.
    Scand J Rheumatol; 1988 Feb 07; 17(5):401-5. PubMed ID: 3145556
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P, Nissilä M, Kajander A, Martio J, von Essen R, Anttila P, Mäkisara GL.
    Scand J Rheumatol; 1978 Feb 07; 7(3):166-70. PubMed ID: 103190
    [Abstract] [Full Text] [Related]

  • 35. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U, Bussmann HU, Jerusalem F.
    Schweiz Med Wochenschr; 1981 Jan 03; 111(1):29-35. PubMed ID: 6782670
    [Abstract] [Full Text] [Related]

  • 36. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E, Lehtinen K, Isomäki H, Nissilä M, Harmoinen A, Mörsky P, Koivula T, Vapaatalo H.
    Int J Clin Pharmacol Res; 1988 Jan 03; 8(3):149-56. PubMed ID: 3136089
    [Abstract] [Full Text] [Related]

  • 37. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL, Samuelson CO, Williams HJ, Ward JR, Karg M.
    Pharmacotherapy; 1990 Jan 03; 10(2):79-84. PubMed ID: 2112243
    [Abstract] [Full Text] [Related]

  • 38. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E.
    Med Clin (Barc); 1985 Jun 08; 85(2):73-9. PubMed ID: 3160899
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of rheumatoid arthritis with penicillamine.
    Hill HF.
    Semin Arthritis Rheum; 1977 May 08; 6(4):361-88. PubMed ID: 323979
    [No Abstract] [Full Text] [Related]

  • 40. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M, Nissilä M, Ruutsalo HM.
    Scand J Rheumatol; 1978 May 08; 7(4):212-4. PubMed ID: 104378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.